Interim and end-treatment 18F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride
Abstract To assess the predictive and prognostic aim of interim and end-treatment 18F-fluorocholine PET/CT (FCH-PET/CT) and 99mTc-methilen diphosphonate bone scintigraphy (BS) in patients with castration-resistant prostate cancer and bone metastases (CRPC-BM) treated with Radium 223 dichloride (223R...
Guardado en:
Autores principales: | Ana María García Vicente, Mariano Amo-Salas, Javier Cassinello Espinosa, Roberto Gómez Díaz, Ángel Soriano Castrejón |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93526451f9f1450195f654660d1da40e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
por: Stephanie I Kim, et al.
Publicado: (2021) -
Usefulness of PET-CT scan in recurrent thyroid cancer
por: Gianlorenzo Dionigi, et al.
Publicado: (2020) -
Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma
por: Gaetano Paone, et al.
Publicado: (2021) -
Elevated radium levels in Nubian Aquifer groundwater of Northeastern Africa
por: Mahmoud I. Sherif, et al.
Publicado: (2021) -
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer
por: Martina Sollini, et al.
Publicado: (2021)